• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK RNA-based Therapeutics Market

    ID: MRFR/HC/50891-HCR
    200 Pages
    Garvit Vyas
    September 2025

    UK RNA-Based Therapeutics Market Research Report By Technology (RNA Interference, Antisense Oligonucleotides, mRNA Therapeutics, CRISPR Technology), By Application (Oncology, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases), By End Use (Pharmaceutical Companies, Research Institutions, Contract Research Organizations) and By Delivery Method (Liposomes, Nanoparticles, Viral Vectors, Electroporation)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK RNA-based Therapeutics Market Research Report — Global Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    UK RNA-based Therapeutics Market Summary

    The United Kingdom South America Ostomy Drainage Bags Devices market is projected to grow steadily over the next decade.

    Key Market Trends & Highlights

    South America Ostomy Drainage Bags Devices Key Trends and Highlights

    • The market valuation is expected to increase from 190.4 USD Million in 2024 to 304.7 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 4.37 percent is anticipated from 2025 to 2035.
    • The growth trajectory indicates a rising demand for ostomy drainage bags in South America, reflecting an expanding patient population.
    • Growing adoption of advanced medical technologies due to increasing awareness of ostomy care is a major market driver.

    Market Size & Forecast

    2024 Market Size 190.4 (USD Million)
    2035 Market Size 304.7 (USD Million)
    CAGR (2025-2035) 4.37%

    Major Players

    Smith & Nephew, B. Braun, Atos Medical, C.R. Bard, Fresenius Kabi, Oakmed, Convatec, Coloplast, Medtronic, 3M, Ring Medical, Vesco Medical, SecuCare, Hernia Solutions, Hollister

    UK RNA-based Therapeutics Market Trends

    In South America, the Ostomy Drainage Bags Devices Market is experiencing several significant trends driven by increasing awareness and acceptance of ostomy procedures. The rising incidence of gastrointestinal diseases, such as colorectal cancer and inflammatory bowel diseases, plays a crucial role in increasing the demand for ostomy products.

    Moreover, the region is witnessing improvements in healthcare infrastructure and access to advanced medical technologies, which are vital drivers for the growth of the ostomy market. Countries like Brazil and Argentina are focusing on enhancing healthcare services and innovative solutions for ostomy patients, fostering a more supportive environment for product adoption.

    Opportunities to be explored in the South American market include the development of more comfortable, user-friendly, and skin-friendly ostomy devices that cater to the unique needs of patients. Manufacturers can capitalize on this by investing in research and development to create specialized products that address local consumer preferences, such as biodegradable materials and skin-friendly adhesives.

    Additionally, public health campaigns and partnerships with healthcare professionals can foster greater awareness and advocacy for ostomy care, leading to increased product uptake. Recent trends in South America reflect a growing emphasis on personalized healthcare solutions, as patients seek tailored ostomy devices that meet their individual lifestyles.

    There is also a shift towards e-commerce platforms, which have gained popularity in the region, making ostomy products more accessible to patients. This trend shows that consumers are increasingly looking for convenient purchasing options without compromising on quality. Overall, the South American Ostomy Drainage Bags Devices Market is poised for growth as the region embraces advancements and evolving patient needs, creating a landscape of opportunities for both existing and new players in the industry.

    UK RNA-based Therapeutics Market Drivers

    Market Segment Insights

    Ostomy Drainage Bags Devices Market Product Type Insights

    The South America Ostomy Drainage Bags Devices Market showcases a comprehensive range of products under the Product Type segment, including Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Ileostomy Bags, and Continent Urostomy Bags. This diverse segmentation is pivotal for addressing the varied needs of patients who have undergone ostomy surgeries due to conditions such as cancer, inflammatory bowel disease, or traumatic injuries.

    Among these, Colostomy Bags hold a significant position, catering to individuals with colostomies, and their design focuses on comfort and discretion, reflecting the lifestyle requirements of users. Ileostomy Bags serve those who have had their ileum diverted, showing the necessity for reliability and skin protection to reduce complications. Urostomy Bags, essential for patients with urinary diversions, emphasize the need for secure and hygienic solutions, as urinary health is crucial for overall well-being.

    Continent Ileostomy Bags and Continent Urostomy Bags reflect the advancements in ostomy care technologies, providing users with more control and comfort. The growing recognition of patient-centric products indicates an upward trend towards innovation in these areas, responding to increasing demand for effective and user-friendly designs. The South America region, characterized by its diverse healthcare systems and improving access to medical devices, continues to benefit from initiatives that enhance the quality of life for ostomy patients.

    In light of the increasing prevalence of lifestyle diseases, the market is poised for sustained growth, presenting numerous opportunities for manufacturers to innovate and expand their offerings in this vital segment of the healthcare industry. Furthermore, governmental and non-governmental organizations in South America are increasingly advocating for better healthcare solutions, which bodes well for the growth trajectory of the ostomy drainage bags market.

    As patients seek quality and reliability, the importance of these various product types in promoting health and comfort cannot be overstated. The evolving landscape of healthcare in South America demonstrates a commitment to improving the standards of care for ostomy patients, highlighting the crucial role of the Product Type segment in addressing their unique healthcare needs effectively.

    Ostomy Drainage Bags Devices Market Procedure Insights

    The South America Ostomy Drainage Bags Devices Market focuses on various procedures, including Colostomy, Urostomy, and Ileostomy, each serving critical roles in providing quality of life for patients requiring ostomy care. Colostomy procedures, which involve diverting a section of the large intestine to an external bag, hold a substantial share of the market due to their extensive need among patients with colorectal conditions, making them a dominant procedure.

    Urostomy, pertaining to the diversion of urine from the bladder, is also significant, particularly in cases of bladder cancer or congenital abnormalities, responding to an increasing patient demographic. Ileostomy, dealing with the removal of the entire colon, is essential for patients with inflammatory bowel diseases like Crohn's disease, showcasing its necessity and consistent demand. The growing prevalence of colorectal cancer and other gastrointestinal disorders drives the market growth, while advancements in materials and technology contribute to the enhanced comfort and usability of ostomy bags.

    Additionally, increasing awareness around ostomy care and patient education initiatives within South America facilitate better acceptance and adherence to ostomy procedures, ultimately impacting the demand for the South America Ostomy Drainage Bags Devices Market. All these factors interplay, contributing to a robust growth trajectory for the Ostomy Drainage Bags Devices Market in the region.

    Ostomy Drainage Bags Devices Market Usage Insights

    The South America Ostomy Drainage Bags Devices Market is seeing significant engagement within its Usage segment, which encompasses both Reusable and Disposable options. The increasing prevalence of chronic diseases and surgeries leading to ostomy procedures has been driving demand for these devices in the region. Reusable bags offer an eco-friendly choice, aligning with growing environmental consciousness among consumers, while Disposable bags provide convenience and ease of use, appealing to caregivers and patients preferring hassle-free maintenance.

    Each option caters to distinct patient needs, with Disposable bags generally dominating the market due to their practicality and lower maintenance requirements. The influence of healthcare reforms and government policies advocating for better patient care is set to support the growth dynamics within this market segment, making it a crucial area of focus for future innovations and solutions in the South American context. This evolution reflects not only the diverse healthcare landscape of South America but also highlights the need for tailored products that address specific consumer preferences and challenges.

    Ostomy Drainage Bags Devices Market System Type Insights

    The South America Ostomy Drainage Bags Devices Market exhibits a notable segmentation in terms of System Type, primarily focusing on One-piece Systems and Two-piece Systems. One-piece systems, which integrate the pouch and the adhesive barrier into a single unit, are often favored for their convenience and simplicity, making them particularly significant for patients seeking ease in daily management. Conversely, Two-piece systems allow for the pouch to be detached from the barrier, offering patients greater flexibility and comfort, especially during activities.

    The demand for these systems is driven by the rising prevalence of conditions requiring ostomy procedures across South America, coupled with an increasing awareness and acceptance of ostomy care. Additionally, advancements in materials and manufacturing processes improve the functionality and effectiveness of these systems, addressing common challenges like leakage and skin irritation. The South America Ostomy Drainage Bags Devices Market statistics reflect a growing need for effective ostomy solutions, presenting opportunities for innovation in designs and materials tailored to the diverse needs of patients.

    As the healthcare landscape continues to evolve, the system type options will likely reflect advancements that enhance patient lifestyles while emphasizing comfort and reliability.

    Ostomy Drainage Bags Devices Market End User Insights

    The South America Ostomy Drainage Bags Devices Market is characterized by a diverse range of End Users, including Hospitals, Clinics, Ambulatory Surgical Centres, Homecare, and Others. Hospitals play a pivotal role in this market, providing critical care and surgical procedures that require ostomy care management, thus accounting for a significant share of usage. Clinics are also essential as they offer outpatient services related to ostomy care, contributing to early detection and preventative measures.

    Ambulatory Surgical Centres are gaining traction due to their focus on non-emergency procedures, making them pivotal for ostomy bag fittings and follow-up care, resulting in growing patient accessibility and convenience. Homecare is emerging as a significant trend driven by an increasing number of patients preferring to manage their postoperative recovery at home, offering personalized care and comfort. The Others category encompasses specialty providers and community care settings, which are increasingly recognized for their contribution to patient education and support.

    Factors such as the rising prevalence of colorectal diseases and improved healthcare infrastructure in South America continue to foster growth across these end-user segments, promoting better quality of life for patients relying on ostomy drainage bags.

    Get more detailed insights about UK RNA-based Therapeutics Market Research Report — Global Forecast till 2035

    Regional Insights

    The South America Ostomy Drainage Bags Devices Market is witnessing steady growth across its various regional segments, driven by increasing healthcare expenditure and a rising prevalence of gastrointestinal diseases. Brazil stands out as a key player in this market, with significant healthcare initiatives aimed at improving ostomy care. Mexico follows closely, where an expanding elderly population is pushing the demand for ostomy products. Argentina's market is characterized by growing awareness regarding ostomy care and support from health authorities, fueling adoption rates of drainage bags and related devices.

    The Rest of South America region reflects a varied landscape, with each country showing unique needs based on healthcare access and patient education initiatives. Overall, the dynamic nature of this region, coupled with supportive government policies aimed at improving healthcare access, positions the South America Ostomy Drainage Bags Devices Market as a significant area for growth, providing numerous opportunities for manufacturers and suppliers in this sector.

    Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

    Key Players and Competitive Insights

    The South America Ostomy Drainage Bags Devices Market is characterized by a diverse competitive landscape where multiple players are vying for market share through innovation, strategic collaborations, and an emphasis on enhancing patient comfort and quality of life. As the prevalence of conditions necessitating ostomy procedures rises due to factors such as increasing gastrointestinal diseases, cancer rates, and advancements in surgical techniques, companies operate in a dynamic environment.

    This market is witnessing a trend toward personalized solutions and technological advancements, such as the integration of smart technology and materials that improve usability and hygiene. Competitive players are focusing on quality assurance, expanding distribution networks, and improving customer service to establish a stronger foothold in this growing market.

    Smith & Nephew has a significant presence in the South America Ostomy Drainage Bags Devices Market, recognized for its strong commitment to improving patient outcomes and innovative product offerings. The company leverages its extensive experience in wound management and durable medical equipment to develop ostomy products that focus on skin protection and comfort. Smith & Nephew's strengths lie in its research and development capabilities, allowing it to introduce cutting-edge solutions tailored to the specific needs of patients in South America.

    The company’s initiatives to enhance awareness and its training programs focused on both healthcare professionals and patients underscore its commitment to providing effective care solutions. Additionally, strategic partnerships and collaborations with local distributors help Smith & Nephew extend its reach, catering to a growing population of ostomy patients in South America.

    B. Braun is another key player in the South America Ostomy Drainage Bags Devices Market, offering a wide range of products designed to meet the needs of ostomy patients. The company’s portfolio includes ostomy bags and accessories that are based on advanced technology, facilitating easier and more hygienic management for users. With a commitment to sustainability and quality, B. Braun has established itself as a trusted name among healthcare providers and patients alike.

    The company's market presence in South America is supported by robust distribution channels and strategic alliances aimed at increasing accessibility to its products. B. Braun has consistently focused on innovation by investing in R&D and has also engaged in mergers and acquisitions that strengthen its market position. This focus on enhancing product capabilities and responsiveness to regional market demands highlights the company's strengths, allowing it to maintain a competitive edge in the evolving landscape of ostomy drainage solutions aimed at improving the quality of life for patients in South America.

    Key Companies in the UK RNA-based Therapeutics Market market include

    Industry Developments

    In recent months, the South America Ostomy Drainage Bags Devices Market has seen noteworthy developments, highlighting the region's dynamic healthcare landscape. Companies like Smith and Nephew, B. Braun, and Coloplast have been at the forefront of innovation, with new product launches aimed at improving patient comfort and quality of life. In February 2023, C.R. Bard announced a collaboration with local healthcare providers to enhance product accessibility in Brazil, while Fresenius Kabi has expanded its production facilities in Argentina to cater to the growing demand for ostomy products.

    Additionally, the market has experienced a notable increase in valuation, primarily driven by the rising prevalence of chronic diseases, such as colorectal cancer, which necessitate ostomy surgeries. Over the past two years, investment activities have surged, with Atos Medical acquiring a regional competitor in November 2022, further consolidating its market position. Regulatory bodies in South America have also been actively working on policies to streamline the approval process for medical devices, contributing positively to market growth.

    The focus is now on providing advanced and accessible healthcare solutions for patients across the region, positioning South America as a critical player in the global ostomy drainage bags devices sector.

    Market Segmentation

    Ostomy Drainage Bags Devices Market Usage Outlook

    • Reusable
    • Disposable

    Ostomy Drainage Bags Devices Market End User Outlook

    • Hospitals
    • Clinics
    • Ambulatory Surgical Centres
    • Homecare
    • Others

    Ostomy Drainage Bags Devices Market Regional Outlook

    • Brazil
    • Mexico
    • Argentina
    • Rest of South America

    Ostomy Drainage Bags Devices Market Procedure Outlook

    • Colostomy
    • Urostomy
    • Ileostomy

    Ostomy Drainage Bags Devices Market System Type Outlook

    • One-piece System
    • Two-piece System

    Ostomy Drainage Bags Devices Market Product Type Outlook

    • Colostomy Bags
    • Ileostomy Bags
    • Urostomy Bags
    • Continent Ileostomy Bags
    • Continent Urostomy Bags

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 288.75(USD Million)
    Market Size 2024 318.38(USD Million)
    Market Size 2035 1148.74(USD Million)
    Compound Annual Growth Rate (CAGR) 12.373% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Million
    Key Companies Profiled Catalent, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, GSK, Moderna, Merck & Co, Regeneron Pharmaceuticals, Pfizer, Novartis, Roche, AstraZeneca, Sanofi, Vertex Pharmaceuticals, BristolMyers Squibb, Bayer
    Segments Covered Technology, Application, End Use, Delivery Method
    Key Market Opportunities Targeting rare genetic disorders, Advancements in delivery technologies, Expansion of clinical trial frameworks, Collaborations with biopharma companies, Growth in personalized medicine approaches
    Key Market Dynamics increased investment in R&D, growing prevalence of genetic disorders, advancements in delivery methods, regulatory support and approvals, rising demand for personalized medicine
    Countries Covered UK

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK RNA-Based Therapeutics Market, BY Technology (USD Million)
    45. RNA Interference
    46. Antisense Oligonucleotides
    47. mRNA Therapeutics
    48. CRISPR Technology
    49. UK RNA-Based Therapeutics Market, BY Application (USD Million)
    50. Oncology
    51. Infectious Diseases
    52. Genetic Disorders
    53. Cardiovascular Diseases
    54. UK RNA-Based Therapeutics Market, BY End Use (USD Million)
    55. Pharmaceutical Companies
    56. Research Institutions
    57. Contract Research Organizations
    58. UK RNA-Based Therapeutics Market, BY Delivery Method (USD Million)
    59. Liposomes
    60. Nanoparticles
    61. Viral Vectors
    62. Electroporation
    63. Competitive Landscape
    64. Overview
    65. Competitive Analysis
    66. Market share Analysis
    67. Major Growth Strategy in the RNA-Based Therapeutics Market
    68. Competitive Benchmarking
    69. Leading Players in Terms of Number of Developments in the RNA-Based Therapeutics Market
    70. Key developments and growth strategies
    71. New Product Launch/Service Deployment
    72. Merger & Acquisitions
    73. Joint Ventures
    74. Major Players Financial Matrix
    75. Sales and Operating Income
    76. Major Players R&D Expenditure. 2023
    77. Company Profiles
    78. Catalent
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. Alnylam Pharmaceuticals
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Ionis Pharmaceuticals
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. GSK
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. Moderna
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. Merck & Co
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Regeneron Pharmaceuticals
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Pfizer
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. Novartis
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Roche
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. AstraZeneca
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Sanofi
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Vertex Pharmaceuticals
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. BristolMyers Squibb
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Bayer
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. References
    169. Related Reports
    170. UK RNA-Based Therapeutics Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    171. UK RNA-Based Therapeutics Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    172. UK RNA-Based Therapeutics Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    173. UK RNA-Based Therapeutics Market SIZE ESTIMATES & FORECAST, BY DELIVERY METHOD, 2019-2035 (USD Billions)
    174. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    175. ACQUISITION/PARTNERSHIP
    176. MARKET SYNOPSIS
    177. UK RNA-BASED THERAPEUTICS MARKET ANALYSIS BY TECHNOLOGY
    178. UK RNA-BASED THERAPEUTICS MARKET ANALYSIS BY APPLICATION
    179. UK RNA-BASED THERAPEUTICS MARKET ANALYSIS BY END USE
    180. UK RNA-BASED THERAPEUTICS MARKET ANALYSIS BY DELIVERY METHOD
    181. KEY BUYING CRITERIA OF RNA-BASED THERAPEUTICS MARKET
    182. RESEARCH PROCESS OF MRFR
    183. DRO ANALYSIS OF RNA-BASED THERAPEUTICS MARKET
    184. DRIVERS IMPACT ANALYSIS: RNA-BASED THERAPEUTICS MARKET
    185. RESTRAINTS IMPACT ANALYSIS: RNA-BASED THERAPEUTICS MARKET
    186. SUPPLY / VALUE CHAIN: RNA-BASED THERAPEUTICS MARKET
    187. RNA-BASED THERAPEUTICS MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    188. RNA-BASED THERAPEUTICS MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    189. RNA-BASED THERAPEUTICS MARKET, BY APPLICATION, 2025 (% SHARE)
    190. RNA-BASED THERAPEUTICS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    191. RNA-BASED THERAPEUTICS MARKET, BY END USE, 2025 (% SHARE)
    192. RNA-BASED THERAPEUTICS MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    193. RNA-BASED THERAPEUTICS MARKET, BY DELIVERY METHOD, 2025 (% SHARE)
    194. RNA-BASED THERAPEUTICS MARKET, BY DELIVERY METHOD, 2019 TO 2035 (USD Billions)
    195. BENCHMARKING OF MAJOR COMPETITORS

    UK RNA-Based Therapeutics Market Segmentation

     

     

     

    • RNA-Based Therapeutics Market By Technology (USD Million, 2019-2035)

      • RNA Interference
      • Antisense Oligonucleotides
      • mRNA Therapeutics
      • CRISPR Technology

     

    • RNA-Based Therapeutics Market By Application (USD Million, 2019-2035)

      • Oncology
      • Infectious Diseases
      • Genetic Disorders
      • Cardiovascular Diseases

     

    • RNA-Based Therapeutics Market By End Use (USD Million, 2019-2035)

      • Pharmaceutical Companies
      • Research Institutions
      • Contract Research Organizations

     

    • RNA-Based Therapeutics Market By Delivery Method (USD Million, 2019-2035)

      • Liposomes
      • Nanoparticles
      • Viral Vectors
      • Electroporation

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials